The Peptide Promise With NervGen Pharma's Mike Kelly скачать в хорошем качестве

The Peptide Promise With NervGen Pharma's Mike Kelly

Mike Kelly faced a self-reckoning before he took the job as CEO at NervGen, a company developing peptide therapeutics targeted specifically at central nervous system repair. The veteran of life sciences business development knew the ropes of the biotech C-suite. He’d been a CEO twice before. He knew how to launch drugs, having seen commercial success several times before. He even knew how to sell them—he’d started his career carrying the bag for TAP Pharmaceuticals. But all he knew about peptides was that they were challenging to manufacture consistently and purify. And he knew that manufacturing is where a lot of biopharma companies fall down. On this episode of the Business of Biotech, we learn how Kelly reconciled that truth, and how NervGen is now leading the way for peptide therapeutics in spinal cord injury and beyond. Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com. Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com Find Matt Pillar on LinkedIn:   / matthewpillar   --- #businessofbiotech #biopharma #biotech Subscribe to the podcast: Apple - https://podcasts.apple.com/us/podcast... Spotify - https://open.spotify.com/show/5NhjpDe... YouTube -    • The Business Of Biotech Podcast